On May 14th, Lesdsynbio was invited to attend the Suzhou Biomanufacturing Industry Development Conference and was awarded the title of " Key Nurturing Enterprise in Biomanufacturing " in Suzhou. The conference, themed "Biomanufacturing Towards Innovation, Future Industry Promising," brought together government representatives , academicians and experts in the field of biomanufacturing .
As a synthetic biology company that has grown up in Suzhou, Lesdsynbio relies on its self-built technology platform to continuously develop original technologies, accumulating 80 patents. Supported by its two major production bases in Hunan and Anhui, it has built a "dual-engine" R&D capability and end-to-end industrialization capability supporting product mass production and commercialization. Currently, the company has achieved large-scale and stable supply of more than ten products with independent intellectual property rights, covering APIs and intermediates, nutritional products, and other fields, with a sales network spanning multiple countries and regions worldwide.
Lesdsynbio has earned numerous honors. Its recognition as a key enterprise for cultivation in Suzhou's biomanufacturing sector signifies further authoritative recognition of Lesdsynbio 's capabilities in technological innovation and industrialization.
Prev:Market | Leadsynbio shines at CPHI China 2026 with a diversified biomanufacturing product portfolio

On June 18–19, China Veterinary Drug Conference and Exhibition 2026 was held at the Hefei Binhu International Convention and Exhibition Center. Anhui Liberty Pharmaceutical Co., Ltd., a wholly‑owned subsidia...
[ Details ]Jun 22,2026